speb/financial-data huggingface dataset:
BMD.L cash_flow (annual, 2025-09-30) — Other Cash Receiptsfrom Operating Activities: 2174000.00
BMD.L balance_sheet (annual, 2025-09-30) — Payables: 1469000.00
BMD.L balance_sheet (quarterly, 2025-09-30) — Payables: 1469000.00
BMD.L balance_sheet (annual, 2025-09-30) — Prepaid Assets: 388000.00
BMD.L balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 388000.00
BMD.L income_statement (annual, 2025-09-30) — Pretax Income: 2569000.00
BMD.L cash_flow (annual, 2025-09-30) — Purchase Of Investment: -39342000.00
BMD.L cash_flow (annual, 2025-09-30) — Sale Of Investment: 52049000.00
BMD.L income_statement (annual, 2025-09-30) — Selling General And Administration: 735000.00
BMD.L balance_sheet (annual, 2025-09-30) — Share Issued: 464333731.00
BMD.L balance_sheet (quarterly, 2025-09-30) — Share Issued: 464333731.00
BMD.L balance_sheet (annual, 2025-09-30) — Stockholders Equity: 221187000.00
BMD.L balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 221187000.00
BMD.L balance_sheet (annual, 2025-09-30) — Tangible Book Value: 221187000.00
BMD.L balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 221187000.00
BMD.L income_statement (annual, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
BMD.L income_statement (annual, 2025-09-30) — Tax Provision: 0.00
BMD.L income_statement (annual, 2025-09-30) — Tax Rate For Calcs: 0.00
BMD.L balance_sheet (annual, 2025-09-30) — Total Assets: 222656000.00
BMD.L balance_sheet (quarterly, 2025-09-30) — Total Assets: 222656000.00
BMD.L balance_sheet (annual, 2025-09-30) — Total Equity Gross Minority Interest: 221187000.00
BMD.L balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 221187000.00
BMD.L balance_sheet (annual, 2025-09-30) — Total Liabilities Net Minority Interest: 1469000.00
BMD.L balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 1469000.00
BMD.L balance_sheet (annual, 2025-09-30) — Treasury Shares Number: 55219256.00
BMD.L balance_sheet (quarterly, 2025-09-30) — Treasury Shares Number: 55219256.00
BMD.L balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 1282000.00
BMD.L balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 40520000.00
BMD.L balance_sheet (quarterly, 2026-03-31) — Capital Stock: 48334000.00
BMD.L balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 580000.00
BMD.L balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Federal Funds Sold: 580000.00
BMD.L balance_sheet (quarterly, 2026-03-31) — Cash Financial: 580000.00
BMD.L balance_sheet (quarterly, 2026-03-31) — Common Stock: 48334000.00
BMD.L balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 197466000.00
BMD.L balance_sheet (quarterly, 2026-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 195199000.00
BMD.L balance_sheet (quarterly, 2026-03-31) — Fixed Assets Revaluation Reserve: 14046000.00
BMD.L balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 195199000.00
BMD.L balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 195199000.00
BMD.L balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 197466000.00
BMD.L balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 420422164.00
BMD.L balance_sheet (quarterly, 2026-03-31) — Payables: 1282000.00
BMD.L balance_sheet (quarterly, 2026-03-31) — Receivables: 2969000.00
BMD.L balance_sheet (quarterly, 2026-03-31) — Share Issued: 483334405.00
BMD.L balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 197466000.00
BMD.L balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 197466000.00
BMD.L balance_sheet (quarterly, 2026-03-31) — Total Assets: 198748000.00
BMD.L balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 197466000.00
BMD.L balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 1282000.00
BMD.L balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 62912241.00
BME balance_sheet (annual, 2021-12-31) — Accounts Payable: 12481544.00
BME income_statement (annual, 2021-12-31) — Basic Average Shares: 12472432.00
BME income_statement (annual, 2021-12-31) — Basic EPS: 4.74
BME cash_flow (annual, 2021-12-31) — Common Stock Issuance: 50328479.00
BME income_statement (annual, 2021-12-31) — Diluted Average Shares: 12472432.00
BME income_statement (annual, 2021-12-31) — Diluted EPS: 4.74
BME cash_flow (annual, 2021-12-31) — Issuance Of Capital Stock: 50328479.00
BME cash_flow (annual, 2021-12-31) — Issuance Of Debt: 0.00
BME cash_flow (annual, 2021-12-31) — Long Term Debt Issuance: 0.00
BME balance_sheet (annual, 2021-12-31) — Prepaid Assets: 0.00
BME income_statement (annual, 2022-12-31) — +Operating Expense: 500130.00
BME income_statement (annual, 2022-12-31) — +Total Revenue: -25970949.00
BME balance_sheet (annual, 2022-12-31) — Accounts Payable: 233198.00
BME balance_sheet (annual, 2022-12-31) — Available For Sale Securities: 23871295.00
BME income_statement (annual, 2022-12-31) — Basic Average Shares: 12605276.00
BME income_statement (annual, 2022-12-31) — Basic EPS: -2.10
BME cash_flow (annual, 2022-12-31) — Beginning Cash Position: 960.00
BME balance_sheet (annual, 2022-12-31) — Capital Stock: 424300067.00
BME balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 3118.00
BME balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Federal Funds Sold: 3118.00
BME cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -32725758.00
BME balance_sheet (annual, 2022-12-31) — Cash Financial: 3118.00
BME cash_flow (annual, 2022-12-31) — Change In Accrued Expense: 3802.00
BME cash_flow (annual, 2022-12-31) — Change In Other Current Assets: 13327.00
BME cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: 464323.00
BME cash_flow (annual, 2022-12-31) — Change In Payable: -9484.00
BME cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: 0.00
BME cash_flow (annual, 2022-12-31) — Change In Receivables: -146886.00
BME cash_flow (annual, 2022-12-31) — Change In Working Capital: 325082.00
BME cash_flow (annual, 2022-12-31) — Changes In Cash: 2126.00
BME balance_sheet (annual, 2022-12-31) — Common Stock: 424300067.00
BME cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: -32725758.00
BME balance_sheet (annual, 2022-12-31) — Common Stock Equity: 600196913.00
BME cash_flow (annual, 2022-12-31) — Common Stock Issuance: 33618939.00
BME cash_flow (annual, 2022-12-31) — Common Stock Payments: 0.00
BME balance_sheet (annual, 2022-12-31) — Derivative Product Liabilities: 4323328.00
BME income_statement (annual, 2022-12-31) — Diluted Average Shares: 12605276.00
BME income_statement (annual, 2022-12-31) — Diluted EPS: -2.10
BME income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -26471079.00
BME cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: 32.00
BME cash_flow (annual, 2022-12-31) — End Cash Position: 3118.00
BME balance_sheet (annual, 2022-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 579806153.00
BME cash_flow (annual, 2022-12-31) — Financing Cash Flow: 876171.00
BME cash_flow (annual, 2022-12-31) — Free Cash Flow: -874045.00
BME cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: 25271952.00
BME income_statement (annual, 2022-12-31) — Gain On Sale Of Security: 13672574.00
BME income_statement (annual, 2022-12-31) — General And Administrative Expense: 362164.00
BME balance_sheet (annual, 2022-12-31) — Invested Capital: 600199833.00
BME balance_sheet (annual, 2022-12-31) — Investmentin Financial Assets: 603679819.00
BME balance_sheet (annual, 2022-12-31) — Investments And Advances: 603679819.00
BME cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 33618939.00
BME balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 2920.00
BME cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 33618939.00
BME balance_sheet (annual, 2022-12-31) — Net Debt: 2920.00
BME income_statement (annual, 2022-12-31) — Net Income: -26471079.00
BME income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -26471079.00
BME income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -26471079.00
BME income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -26471079.00
BME income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -26471079.00
BME cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -26471079.00
BME income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -26471079.00
BME cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 2920.00
BME cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 2920.00
BME cash_flow (annual, 2022-12-31) — Net Other Financing Charges: 0.00
BME balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 600196913.00
BME income_statement (annual, 2022-12-31) — Normalized Income: -26471079.00
BME cash_flow (annual, 2022-12-31) — Operating Cash Flow: -874045.00
BME income_statement (annual, 2022-12-31) — Operating Revenue: -25970949.00
BME balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 13860528.00
BME income_statement (annual, 2022-12-31) — Other Operating Expenses: 137966.00
BME balance_sheet (annual, 2022-12-31) — Other Payable: 658831.00
BME balance_sheet (annual, 2022-12-31) — Payables: 892029.00
BME income_statement (annual, 2022-12-31) — Pretax Income: -26471079.00
BME balance_sheet (annual, 2022-12-31) — Receivables: 2368513.00
BME cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: 0.00
BME balance_sheet (annual, 2022-12-31) — Retained Earnings: 175896846.00
BME income_statement (annual, 2022-12-31) — Selling General And Administration: 362164.00
BME balance_sheet (annual, 2022-12-31) — Share Issued: 13860528.00
BME balance_sheet (annual, 2022-12-31) — Stockholders Equity: 600196913.00
BME balance_sheet (annual, 2022-12-31) — Tangible Book Value: 600196913.00
BME income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
BME income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.00
BME balance_sheet (annual, 2022-12-31) — Total Assets: 606129624.00
BME balance_sheet (annual, 2022-12-31) — Total Capitalization: 600199833.00
BME balance_sheet (annual, 2022-12-31) — Total Debt: 2920.00
BME balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 600196913.00
BME balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 5932711.00
BME income_statement (annual, 2023-12-31) — +Operating Expense: 393597.00
BME income_statement (annual, 2023-12-31) — +Total Revenue: 20410615.00
BME balance_sheet (annual, 2023-12-31) — Available For Sale Securities: 31396977.00
BME income_statement (annual, 2023-12-31) — Basic Average Shares: 13900707.00
BME income_statement (annual, 2023-12-31) — Basic EPS: 1.44
BME cash_flow (annual, 2023-12-31) — Beginning Cash Position: 3118.00
BME balance_sheet (annual, 2023-12-31) — Capital Stock: 417617800.00
BME balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 534.00
BME balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Federal Funds Sold: 534.00
BME cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -35099184.00
BME balance_sheet (annual, 2023-12-31) — Cash Financial: 534.00
BME cash_flow (annual, 2023-12-31) — Change In Accrued Expense: -24844.00
BME cash_flow (annual, 2023-12-31) — Change In Other Current Assets: -4426.00
BME cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: -675895.00
BME cash_flow (annual, 2023-12-31) — Change In Payable: -37125.00
BME cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: -5292.00
BME cash_flow (annual, 2023-12-31) — Change In Receivables: -17819.00
BME cash_flow (annual, 2023-12-31) — Change In Working Capital: -765401.00
BME cash_flow (annual, 2023-12-31) — Changes In Cash: -2556.00
BME balance_sheet (annual, 2023-12-31) — Common Stock: 417617800.00
BME cash_flow (annual, 2023-12-31) — Common Stock Dividend Paid: -35099184.00
BME balance_sheet (annual, 2023-12-31) — Common Stock Equity: 588135430.00
BME cash_flow (annual, 2023-12-31) — Common Stock Issuance: 3020683.00
BME cash_flow (annual, 2023-12-31) — Common Stock Payments: 0.00
BME balance_sheet (annual, 2023-12-31) — Derivative Product Liabilities: 7272745.00
BME income_statement (annual, 2023-12-31) — Diluted Average Shares: 13900707.00
BME income_statement (annual, 2023-12-31) — Diluted EPS: 1.44
BME income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 20017018.00
BME cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: -28.00
BME cash_flow (annual, 2023-12-31) — End Cash Position: 534.00
BME balance_sheet (annual, 2023-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 563003221.00
BME cash_flow (annual, 2023-12-31) — Financing Cash Flow: -32021232.00
BME cash_flow (annual, 2023-12-31) — Free Cash Flow: 32018676.00
BME cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: 12767059.00
BME income_statement (annual, 2023-12-31) — Gain On Sale Of Security: 26702159.00
BME income_statement (annual, 2023-12-31) — General And Administrative Expense: 299026.00
BME income_statement (annual, 2023-12-31) — Interest Expense: 55.00
BME income_statement (annual, 2023-12-31) — Interest Income: 0.00
BME balance_sheet (annual, 2023-12-31) — Invested Capital: 588196116.00
BME balance_sheet (annual, 2023-12-31) — Investmentin Financial Assets: 594400473.00
BME balance_sheet (annual, 2023-12-31) — Investments And Advances: 594400473.00
BME cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 3020683.00
BME balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 60686.00
BME cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 3020683.00
BME balance_sheet (annual, 2023-12-31) — Net Debt: 60152.00
BME income_statement (annual, 2023-12-31) — Net Income: 20017018.00
BME income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 20017018.00
BME income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 20017018.00
BME income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 20017018.00
BME income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 20017018.00
BME cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 20017018.00
BME income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 20017018.00
BME income_statement (annual, 2023-12-31) — Net Interest Income: -55.00
BME cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 57766.00
BME cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 57766.00
BME cash_flow (annual, 2023-12-31) — Net Other Financing Charges: 0.00
BME balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 588135430.00
BME income_statement (annual, 2023-12-31) — Normalized Income: 20017018.00
BME cash_flow (annual, 2023-12-31) — Operating Cash Flow: 32018676.00
BME income_statement (annual, 2023-12-31) — Operating Revenue: 20410615.00
BME balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 13943973.00
BME income_statement (annual, 2023-12-31) — Other Operating Expenses: 94571.00
BME balance_sheet (annual, 2023-12-31) — Other Payable: 621390.00
BME balance_sheet (annual, 2023-12-31) — Payables: 621390.00
BME balance_sheet (annual, 2023-12-31) — Prepaid Assets: 5292.00
BME income_statement (annual, 2023-12-31) — Pretax Income: 20017018.00
BME balance_sheet (annual, 2023-12-31) — Receivables: 1615047.00
BME cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: 0.00
BME balance_sheet (annual, 2023-12-31) — Retained Earnings: 170517630.00
BME income_statement (annual, 2023-12-31) — Selling General And Administration: 299026.00
BME balance_sheet (annual, 2023-12-31) — Share Issued: 13943973.00
BME balance_sheet (annual, 2023-12-31) — Stockholders Equity: 588135430.00
BME balance_sheet (annual, 2023-12-31) — Tangible Book Value: 588135430.00
BME income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
BME income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.21
BME balance_sheet (annual, 2023-12-31) — Total Assets: 596103946.00
BME balance_sheet (annual, 2023-12-31) — Total Capitalization: 588196116.00
BME balance_sheet (annual, 2023-12-31) — Total Debt: 60686.00
BME balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 588135430.00
BME balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 7968516.00
BME income_statement (annual, 2024-12-31) — +Operating Expense: 617092.00
BME income_statement (annual, 2024-12-31) — +Total Revenue: 24071879.00
BME balance_sheet (annual, 2024-12-31) — Accounts Payable: 493107.00
BME balance_sheet (quarterly, 2024-12-31) — Accounts Payable: 493107.00
BME balance_sheet (annual, 2024-12-31) — Available For Sale Securities: 26552753.00
BME balance_sheet (quarterly, 2024-12-31) — Available For Sale Securities: 26552753.00
BME income_statement (annual, 2024-12-31) — Basic Average Shares: 14389440.00
BME income_statement (annual, 2024-12-31) — Basic EPS: 1.63
BME cash_flow (annual, 2024-12-31) — Beginning Cash Position: 534.00
BME balance_sheet (annual, 2024-12-31) — Capital Stock: 381133280.00
BME balance_sheet (quarterly, 2024-12-31) — Capital Stock: 381133280.00
BME balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 6048.00
BME balance_sheet (quarterly, 2024-12-31) — Cash And Cash Equivalents: 6048.00
BME balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Federal Funds Sold: 6048.00
BME balance_sheet (quarterly, 2024-12-31) — Cash Cash Equivalents And Federal Funds Sold: 6048.00
BME cash_flow (annual, 2024-12-31) — Cash Dividends Paid: -35922238.00
BME balance_sheet (annual, 2024-12-31) — Cash Financial: 6048.00
BME balance_sheet (quarterly, 2024-12-31) — Cash Financial: 6048.00
BME cash_flow (annual, 2024-12-31) — Change In Accrued Expense: 2044.00
BME cash_flow (annual, 2024-12-31) — Change In Other Current Assets: -1999.00
BME cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: 278058.00
BME cash_flow (annual, 2024-12-31) — Change In Payable: 9962.00
BME cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: 5292.00
BME cash_flow (annual, 2024-12-31) — Change In Receivables: 215907.00
BME cash_flow (annual, 2024-12-31) — Change In Working Capital: 509264.00
BME cash_flow (annual, 2024-12-31) — Changes In Cash: 5521.00
BME balance_sheet (annual, 2024-12-31) — Common Stock: 381133280.00
BME balance_sheet (quarterly, 2024-12-31) — Common Stock: 381133280.00
BME cash_flow (annual, 2024-12-31) — Common Stock Dividend Paid: -35922238.00
BME balance_sheet (annual, 2024-12-31) — Common Stock Equity: 546135264.00
BME balance_sheet (quarterly, 2024-12-31) — Common Stock Equity: 546135264.00
BME cash_flow (annual, 2024-12-31) — Common Stock Payments: -29532715.00
BME balance_sheet (annual, 2024-12-31) — Derivative Product Liabilities: 2822101.00
BME balance_sheet (quarterly, 2024-12-31) — Derivative Product Liabilities: 2822101.00
BME income_statement (annual, 2024-12-31) — Diluted Average Shares: 14389440.00
BME income_statement (annual, 2024-12-31) — Diluted EPS: 1.63
BME income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 23454787.00
BME cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: -7.00
BME cash_flow (annual, 2024-12-31) — End Cash Position: 6048.00
BME balance_sheet (annual, 2024-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 523326668.00
BME balance_sheet (quarterly, 2024-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 523326668.00
BME cash_flow (annual, 2024-12-31) — Financing Cash Flow: -65515639.00
BME cash_flow (annual, 2024-12-31) — Free Cash Flow: 65521160.00
BME cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: 41557109.00
BME income_statement (annual, 2024-12-31) — Gain On Sale Of Security: 28761252.00
BME income_statement (annual, 2024-12-31) — General And Administrative Expense: 355526.00
BME income_statement (annual, 2024-12-31) — Interest Expense: 78.00
BME income_statement (annual, 2024-12-31) — Interest Income: 0.00
BME balance_sheet (annual, 2024-12-31) — Invested Capital: 768719076.00
BME balance_sheet (quarterly, 2024-12-31) — Invested Capital: 768719076.00
BME balance_sheet (annual, 2024-12-31) — Investmentin Financial Assets: 549880371.00
BME balance_sheet (quarterly, 2024-12-31) — Investmentin Financial Assets: 549880371.00
BME balance_sheet (annual, 2024-12-31) — Investments And Advances: 549880371.00
BME balance_sheet (quarterly, 2024-12-31) — Investments And Advances: 549880371.00
BME balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 152061.00
BME balance_sheet (quarterly, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 152061.00
BME cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: -29532715.00
BME balance_sheet (annual, 2024-12-31) — Net Debt: 80722.00
BME balance_sheet (quarterly, 2024-12-31) — Net Debt: 80722.00
BME income_statement (annual, 2024-12-31) — Net Income: 23454787.00
BME income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 23454787.00
BME income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 23454787.00
BME income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 23454787.00
BME income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 23454787.00
BME cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 23454787.00
BME income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 23454787.00
BME income_statement (annual, 2024-12-31) — Net Interest Income: -78.00
BME cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -60686.00
BME cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -60686.00
BME cash_flow (annual, 2024-12-31) — Net Other Financing Charges: 0.00
BME balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 546135264.00
BME balance_sheet (quarterly, 2024-12-31) — Net Tangible Assets: 546135264.00
BME income_statement (annual, 2024-12-31) — Normalized Income: 23454787.00
BME cash_flow (annual, 2024-12-31) — Operating Cash Flow: 65521160.00
BME income_statement (annual, 2024-12-31) — Operating Revenue: 24071879.00
BME balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 13255490.00
BME balance_sheet (quarterly, 2024-12-31) — Ordinary Shares Number: 13255490.00
BME income_statement (annual, 2024-12-31) — Other Operating Expenses: 261566.00
BME balance_sheet (annual, 2024-12-31) — Other Payable: 631171.00
BME balance_sheet (quarterly, 2024-12-31) — Other Payable: 631171.00
BME balance_sheet (annual, 2024-12-31) — Payables: 1124278.00
BME balance_sheet (quarterly, 2024-12-31) — Payables: 1124278.00
BME balance_sheet (annual, 2024-12-31) — Prepaid Assets: 0.00
BME balance_sheet (quarterly, 2024-12-31) — Prepaid Assets: 0.00
BME income_statement (annual, 2024-12-31) — Pretax Income: 23454787.00
BME balance_sheet (annual, 2024-12-31) — Receivables: 404422.00
BME balance_sheet (quarterly, 2024-12-31) — Receivables: 404422.00
BME cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -29532715.00
BME balance_sheet (annual, 2024-12-31) — Retained Earnings: 165001984.00
BME balance_sheet (quarterly, 2024-12-31) — Retained Earnings: 165001984.00
BME income_statement (annual, 2024-12-31) — Selling General And Administration: 355526.00
BME balance_sheet (annual, 2024-12-31) — Share Issued: 13255490.00
BME balance_sheet (quarterly, 2024-12-31) — Share Issued: 13255490.00
BME balance_sheet (annual, 2024-12-31) — Stockholders Equity: 546135264.00
BME balance_sheet (quarterly, 2024-12-31) — Stockholders Equity: 546135264.00
BME balance_sheet (annual, 2024-12-31) — Tangible Book Value: 546135264.00
BME balance_sheet (quarterly, 2024-12-31) — Tangible Book Value: 546135264.00
BME income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
BME income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.21
BME balance_sheet (annual, 2024-12-31) — Total Assets: 550375440.00
BME balance_sheet (quarterly, 2024-12-31) — Total Assets: 550375440.00
BME balance_sheet (annual, 2024-12-31) — Total Capitalization: 768719076.00
BME balance_sheet (quarterly, 2024-12-31) — Total Capitalization: 768719076.00
BME balance_sheet (annual, 2024-12-31) — Total Debt: 152061.00
BME balance_sheet (quarterly, 2024-12-31) — Total Debt: 152061.00
BME balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 546135264.00
BME balance_sheet (quarterly, 2024-12-31) — Total Equity Gross Minority Interest: 546135264.00
BME balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 4240176.00
BME balance_sheet (quarterly, 2024-12-31) — Total Liabilities Net Minority Interest: 4240176.00
BME balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 14296927.00
BME balance_sheet (quarterly, 2025-06-30) — Available For Sale Securities: 22508070.00
BME balance_sheet (quarterly, 2025-06-30) — Capital Stock: 367155641.00
BME balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 39397.00
BME balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Federal Funds Sold: 39397.00
BME balance_sheet (quarterly, 2025-06-30) — Cash Financial: 39397.00
BME balance_sheet (quarterly, 2025-06-30) — Common Stock: 367155641.00
BME balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 508097810.00
BME balance_sheet (quarterly, 2025-06-30) — Derivative Product Liabilities: 4276183.00
BME balance_sheet (quarterly, 2025-06-30) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 504361297.00
BME balance_sheet (quarterly, 2025-06-30) — Investmentin Financial Assets: 526869367.00
BME balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 526869367.00
BME balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 508097810.00
BME balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 12924103.00
BME balance_sheet (quarterly, 2025-06-30) — Other Payable: 529825.00
BME balance_sheet (quarterly, 2025-06-30) — Payables: 14826752.00
BME balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 0.00
BME balance_sheet (quarterly, 2025-06-30) — Receivables: 1717053.00
BME balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 140942169.00
BME balance_sheet (quarterly, 2025-06-30) — Share Issued: 12924103.00
BME balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 508097810.00
BME balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 508097810.00
BME balance_sheet (quarterly, 2025-06-30) — Total Assets: 528625817.00
BME balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 508097810.00
BME balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 20528007.00
BME income_statement (annual, 2025-12-31) — +Operating Expense: 566628.00
BME income_statement (annual, 2025-12-31) — +Total Revenue: 77535845.00
BME balance_sheet (annual, 2025-12-31) — Accounts Payable: 211959.00
BME balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 211959.00
BME balance_sheet (annual, 2025-12-31) — Available For Sale Securities: 4915133.00
BME balance_sheet (quarterly, 2025-12-31) — Available For Sale Securities: 4915133.00
BME cash_flow (annual, 2025-12-31) — Beginning Cash Position: 6048.00
BME balance_sheet (annual, 2025-12-31) — Capital Stock: 357612495.00
BME balance_sheet (quarterly, 2025-12-31) — Capital Stock: 357612495.00
BME balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 548.00
BME balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 548.00
BME balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Federal Funds Sold: 548.00
BME balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Federal Funds Sold: 548.00
BME cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -40610643.00
BME balance_sheet (annual, 2025-12-31) — Cash Financial: 548.00
BME balance_sheet (quarterly, 2025-12-31) — Cash Financial: 548.00
BME cash_flow (annual, 2025-12-31) — Change In Accrued Expense: 3323.00
BME cash_flow (annual, 2025-12-31) — Change In Other Current Assets: 68802.00
BME cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: 0.00
BME cash_flow (annual, 2025-12-31) — Change In Payable: 76764.00
BME cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: 0.00
BME cash_flow (annual, 2025-12-31) — Change In Receivables: 590845.00
BME cash_flow (annual, 2025-12-31) — Change In Working Capital: 739734.00
BME cash_flow (annual, 2025-12-31) — Changes In Cash: -5510.00
BME balance_sheet (annual, 2025-12-31) — Common Stock: 357612495.00
BME balance_sheet (quarterly, 2025-12-31) — Common Stock: 357612495.00
BME cash_flow (annual, 2025-12-31) — Common Stock Dividend Paid: -40610643.00
BME balance_sheet (annual, 2025-12-31) — Common Stock Equity: 568304240.00
BME balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 568304240.00
BME cash_flow (annual, 2025-12-31) — Common Stock Payments: -13977639.00
BME balance_sheet (annual, 2025-12-31) — Derivative Product Liabilities: 0.00
BME balance_sheet (quarterly, 2025-12-31) — Derivative Product Liabilities: 0.00
BME income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 76969217.00
BME cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 10.00
BME cash_flow (annual, 2025-12-31) — End Cash Position: 548.00
BME balance_sheet (annual, 2025-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 564776575.00
BME balance_sheet (quarterly, 2025-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 564776575.00
BME cash_flow (annual, 2025-12-31) — Financing Cash Flow: -54588282.00
BME cash_flow (annual, 2025-12-31) — Free Cash Flow: 54582772.00
BME cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: -23126179.00
BME income_statement (annual, 2025-12-31) — Gain On Sale Of Security: 28423697.00
BME income_statement (annual, 2025-12-31) — General And Administrative Expense: 439053.00
BME income_statement (annual, 2025-12-31) — Interest Expense: 87.00
BME income_statement (annual, 2025-12-31) — Interest Income: 0.00
BME balance_sheet (annual, 2025-12-31) — Investmentin Financial Assets: 569693045.00
BME balance_sheet (quarterly, 2025-12-31) — Investmentin Financial Assets: 569693045.00
BME balance_sheet (annual, 2025-12-31) — Investments And Advances: 569693045.00
BME balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 569693045.00
BME cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -13977639.00
BME income_statement (annual, 2025-12-31) — Net Income: 76969217.00
BME income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 76969217.00
BME income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 76969217.00
BME income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 76969217.00
BME income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 76969217.00
BME cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 76969217.00
BME income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 76969217.00
BME income_statement (annual, 2025-12-31) — Net Interest Income: -87.00
BME cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 0.00
BME cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 0.00
BME cash_flow (annual, 2025-12-31) — Net Other Financing Charges: 0.00
BME balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 568304240.00
BME balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 568304240.00
BME income_statement (annual, 2025-12-31) — Normalized Income: 76969217.00
BME cash_flow (annual, 2025-12-31) — Operating Cash Flow: 54582772.00
BME income_statement (annual, 2025-12-31) — Operating Revenue: 77535845.00
BME balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 12924103.00
BME balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 12924103.00
BME income_statement (annual, 2025-12-31) — Other Operating Expenses: 127575.00
BME balance_sheet (annual, 2025-12-31) — Other Payable: 707935.00
BME balance_sheet (quarterly, 2025-12-31) — Other Payable: 707935.00
BME balance_sheet (annual, 2025-12-31) — Payables: 919894.00
BME balance_sheet (quarterly, 2025-12-31) — Payables: 919894.00
BME income_statement (annual, 2025-12-31) — Pretax Income: 76969217.00
BME balance_sheet (annual, 2025-12-31) — Receivables: 428138.00
BME balance_sheet (quarterly, 2025-12-31) — Receivables: 428138.00
BME cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -13977639.00
BME income_statement (annual, 2025-12-31) — Restructuring And Mergern Acquisition: 0.00
BME balance_sheet (annual, 2025-12-31) — Retained Earnings: 210691745.00
BME balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 210691745.00
BME income_statement (annual, 2025-12-31) — Selling General And Administration: 439053.00
BME balance_sheet (annual, 2025-12-31) — Share Issued: 12924103.00
BME balance_sheet (quarterly, 2025-12-31) — Share Issued: 12924103.00
BME income_statement (annual, 2025-12-31) — Special Income Charges: 0.00
BME balance_sheet (annual, 2025-12-31) — Stockholders Equity: 568304240.00
BME balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 568304240.00
BME balance_sheet (annual, 2025-12-31) — Tangible Book Value: 568304240.00
BME balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 568304240.00
BME income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
BME income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.21
BME balance_sheet (annual, 2025-12-31) — Taxes Receivable: 0.00
BME balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 0.00
BME balance_sheet (annual, 2025-12-31) — Total Assets: 570137528.00
BME balance_sheet (quarterly, 2025-12-31) — Total Assets: 570137528.00
BME balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 568304240.00
BME balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 568304240.00
BME balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 1833288.00
BME balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 1833288.00
BME income_statement (annual, 2025-12-31) — Total Unusual Items: 0.00
BME income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 0.00
BME.L income_statement (annual, 2022-03-31) — +Operating Expense: 1142000000.00
BME.L income_statement (annual, 2022-03-31) — +Total Revenue: 4673000000.00
BME.L balance_sheet (annual, 2022-03-31) — Accounts Payable: 415000000.00
BME.L balance_sheet (annual, 2022-03-31) — Accounts Receivable: 17000000.00
BME.L balance_sheet (annual, 2022-03-31) — Accumulated Depreciation: -250000000.00
BME.L balance_sheet (annual, 2022-03-31) — Additional Paid In Capital: 2476000000.00
BME.L balance_sheet (annual, 2022-03-31) — Allowance For Doubtful Accounts Receivable: -2000000.00
BME.L cash_flow (annual, 2022-03-31) — Amortization Cash Flow: 2000000.00
BME.L income_statement (annual, 2022-03-31) — Basic Average Shares: 1001061000.00
BME.L income_statement (annual, 2022-03-31) — Basic EPS: 0.42
BME.L cash_flow (annual, 2022-03-31) — Beginning Cash Position: 218000000.00
BME.L balance_sheet (annual, 2022-03-31) — Buildings And Improvements: 1053000000.00
BME.L cash_flow (annual, 2022-03-31) — Capital Expenditure: -100000000.00
BME.L balance_sheet (annual, 2022-03-31) — Capital Lease Obligations: 1310000000.00
BME.L balance_sheet (annual, 2022-03-31) — Capital Stock: 100000000.00
BME.L balance_sheet (annual, 2022-03-31) — Cash And Cash Equivalents: 173000000.00
BME.L balance_sheet (annual, 2022-03-31) — Cash Cash Equivalents And Short Term Investments: 173000000.00
BME.L cash_flow (annual, 2022-03-31) — Cash Dividends Paid: -430000000.00
BME.L balance_sheet (annual, 2022-03-31) — Cash Financial: 173000000.00
BME.L cash_flow (annual, 2022-03-31) — Change In Inventory: -260000000.00
BME.L cash_flow (annual, 2022-03-31) — Change In Payable: 40000000.00
BME.L cash_flow (annual, 2022-03-31) — Change In Receivables: -12000000.00
BME.L cash_flow (annual, 2022-03-31) — Change In Working Capital: -230000000.00
BME.L cash_flow (annual, 2022-03-31) — Changes In Cash: -44000000.00
BME.L balance_sheet (annual, 2022-03-31) — Common Stock: 100000000.00
BME.L cash_flow (annual, 2022-03-31) — Common Stock Dividend Paid: -430000000.00
BME.L balance_sheet (annual, 2022-03-31) — Common Stock Equity: 746000000.00
BME.L cash_flow (annual, 2022-03-31) — Common Stock Issuance: 0.00
BME.L income_statement (annual, 2022-03-31) — Cost Of Revenue: 2921000000.00
BME.L balance_sheet (annual, 2022-03-31) — Current Assets: 1123000000.00
BME.L balance_sheet (annual, 2022-03-31) — Current Capital Lease Obligation: 170000000.00
BME.L balance_sheet (annual, 2022-03-31) — Current Debt: 6000000.00
BME.L balance_sheet (annual, 2022-03-31) — Current Debt And Capital Lease Obligation: 176000000.00
BME.L balance_sheet (annual, 2022-03-31) — Current Liabilities: 755000000.00
BME.L balance_sheet (annual, 2022-03-31) — Current Provisions: 11000000.00
BME.L cash_flow (annual, 2022-03-31) — Depreciation: 225000000.00
BME.L cash_flow (annual, 2022-03-31) — Depreciation And Amortization: 227000000.00
BME.L income_statement (annual, 2022-03-31) — Diluted Average Shares: 1002954000.00
BME.L income_statement (annual, 2022-03-31) — Diluted EPS: 0.42
BME.L income_statement (annual, 2022-03-31) — Diluted NI Availto Com Stockholders: 422000000.00
BME.L cash_flow (annual, 2022-03-31) — Dividends Received Cfi: 0.00
BME.L income_statement (annual, 2022-03-31) — EBIT: 611000000.00
BME.L income_statement (annual, 2022-03-31) — EBITDA: 838000000.00
BME.L cash_flow (annual, 2022-03-31) — Effect Of Exchange Rate Changes: -1000000.00
BME.L cash_flow (annual, 2022-03-31) — End Cash Position: 173000000.00
BME.L cash_flow (annual, 2022-03-31) — Financing Cash Flow: -450000000.00
BME.L balance_sheet (annual, 2022-03-31) — Finished Goods: 863000000.00
BME.L cash_flow (annual, 2022-03-31) — Free Cash Flow: 391000000.00
BME.L cash_flow (annual, 2022-03-31) — Gain Loss On Investment Securities: -13000000.00
BME.L cash_flow (annual, 2022-03-31) — Gain Loss On Sale Of PPE: 0.00
BME.L income_statement (annual, 2022-03-31) — General And Administrative Expense: 1142000000.00
BME.L balance_sheet (annual, 2022-03-31) — Goodwill: 920000000.00
BME.L balance_sheet (annual, 2022-03-31) — Goodwill And Other Intangible Assets: 1040000000.00
BME.L balance_sheet (annual, 2022-03-31) — Gross Accounts Receivable: 19000000.00
BME.L balance_sheet (annual, 2022-03-31) — Gross PPE: 1679000000.00
BME.L income_statement (annual, 2022-03-31) — Gross Profit: 1752000000.00
BME.L balance_sheet (annual, 2022-03-31) — Hedging Assets Current: 25000000.00
BME.L income_statement (annual, 2022-03-31) — Interest Expense: 86000000.00
BME.L income_statement (annual, 2022-03-31) — Interest Expense Non Operating: 86000000.00
BME.L income_statement (annual, 2022-03-31) — Interest Income: 0.00
BME.L income_statement (annual, 2022-03-31) — Interest Income Non Operating: 0.00
BME.L cash_flow (annual, 2022-03-31) — Interest Paid Cff: -83000000.00
BME.L cash_flow (annual, 2022-03-31) — Interest Received Cfi: 0.00
BME.L balance_sheet (annual, 2022-03-31) — Inventory: 863000000.00
BME.L balance_sheet (annual, 2022-03-31) — Invested Capital: 1702000000.00
BME.L cash_flow (annual, 2022-03-31) — Investing Cash Flow: -85000000.00
BME.L balance_sheet (annual, 2022-03-31) — Investmentsin Associatesat Cost: 8000000.00
BME.L cash_flow (annual, 2022-03-31) — Issuance Of Capital Stock: 0.00
BME.L cash_flow (annual, 2022-03-31) — Issuance Of Debt: 251000000.00
BME.L balance_sheet (annual, 2022-03-31) — Land And Improvements: 82000000.00
BME.L balance_sheet (annual, 2022-03-31) — Long Term Capital Lease Obligation: 1140000000.00
BME.L balance_sheet (annual, 2022-03-31) — Long Term Debt: 950000000.00
BME.L balance_sheet (annual, 2022-03-31) — Long Term Debt And Capital Lease Obligation: 2090000000.00
BME.L cash_flow (annual, 2022-03-31) — Long Term Debt Issuance: 251000000.00
BME.L cash_flow (annual, 2022-03-31) — Long Term Debt Payments: -26000000.00
BME.L balance_sheet (annual, 2022-03-31) — Long Term Equity Investment: 8000000.00
BME.L balance_sheet (annual, 2022-03-31) — Long Term Provisions: 4000000.00
BME.L balance_sheet (annual, 2022-03-31) — Machinery Furniture Equipment: 539000000.00
BME.L cash_flow (annual, 2022-03-31) — Net Business Purchase And Sale: 0.00
BME.L cash_flow (annual, 2022-03-31) — Net Common Stock Issuance: 0.00
BME.L balance_sheet (annual, 2022-03-31) — Net Debt: 783000000.00
BME.L income_statement (annual, 2022-03-31) — Net Income: 422000000.00
BME.L income_statement (annual, 2022-03-31) — Net Income Common Stockholders: 422000000.00
BME.L income_statement (annual, 2022-03-31) — Net Income Continuous Operations: 422000000.00
BME.L income_statement (annual, 2022-03-31) — Net Income From Continuing And Discontinued Operation: 422000000.00
BME.L income_statement (annual, 2022-03-31) — Net Income From Continuing Operation Net Minority Interest: 422000000.00
BME.L cash_flow (annual, 2022-03-31) — Net Income From Continuing Operations: 525000000.00
BME.L income_statement (annual, 2022-03-31) — Net Income Including Noncontrolling Interests: 422000000.00
BME.L cash_flow (annual, 2022-03-31) — Net Intangibles Purchase And Sale: -4000000.00
BME.L income_statement (annual, 2022-03-31) — Net Interest Income: -88000000.00
BME.L cash_flow (annual, 2022-03-31) — Net Issuance Payments Of Debt: 225000000.00
BME.L cash_flow (annual, 2022-03-31) — Net Long Term Debt Issuance: 225000000.00
BME.L income_statement (annual, 2022-03-31) — Net Non Operating Interest Income Expense: -88000000.00
BME.L balance_sheet (annual, 2022-03-31) — Net PPE: 1429000000.00
BME.L cash_flow (annual, 2022-03-31) — Net PPE Purchase And Sale: -81000000.00
BME.L cash_flow (annual, 2022-03-31) — Net Short Term Debt Issuance: 0.00
BME.L balance_sheet (annual, 2022-03-31) — Net Tangible Assets: -294000000.00
BME.L balance_sheet (annual, 2022-03-31) — Non Current Deferred Taxes Assets: 31000000.00
BME.L balance_sheet (annual, 2022-03-31) — Non Current Deferred Taxes Liabilities: 43000000.00
BME.L income_statement (annual, 2022-03-31) — Normalized EBITDA: 838000000.00
BME.L income_statement (annual, 2022-03-31) — Normalized Income: 422000000.00
BME.L cash_flow (annual, 2022-03-31) — Operating Cash Flow: 491000000.00
BME.L income_statement (annual, 2022-03-31) — Operating Income: 610000000.00
BME.L income_statement (annual, 2022-03-31) — Operating Revenue: 4673000000.00
BME.L balance_sheet (annual, 2022-03-31) — Ordinary Shares Number: 1001226836.00
BME.L balance_sheet (annual, 2022-03-31) — Other Intangible Assets: 120000000.00
BME.L cash_flow (annual, 2022-03-31) — Other Non Cash Items: 88000000.00
BME.L balance_sheet (annual, 2022-03-31) — Other Payable: 12000000.00
BME.L balance_sheet (annual, 2022-03-31) — Other Properties: 5000000.00
BME.L balance_sheet (annual, 2022-03-31) — Other Receivables: 13000000.00
BME.L income_statement (annual, 2022-03-31) — Otherunder Preferred Stock Dividend: 0.00
BME.L balance_sheet (annual, 2022-03-31) — Payables: 493000000.00
BME.L balance_sheet (annual, 2022-03-31) — Prepaid Assets: 20000000.00
BME.L income_statement (annual, 2022-03-31) — Pretax Income: 525000000.00
BME.L balance_sheet (annual, 2022-03-31) — Properties: 0.00
BME.L cash_flow (annual, 2022-03-31) — Purchase Of Intangibles: -4000000.00
BME.L cash_flow (annual, 2022-03-31) — Purchase Of PPE: -96000000.00
BME.L income_statement (annual, 2022-03-31) — Reconciled Cost Of Revenue: 2921000000.00
BME.L income_statement (annual, 2022-03-31) — Reconciled Depreciation: 227000000.00
BME.L income_statement (annual, 2022-03-31) — Rent Expense Supplemental: 2000000.00
BME.L cash_flow (annual, 2022-03-31) — Repayment Of Debt: -26000000.00
BME.L balance_sheet (annual, 2022-03-31) — Retained Earnings: 121000000.00
BME.L cash_flow (annual, 2022-03-31) — Sale Of Business: 0.00
BME.L cash_flow (annual, 2022-03-31) — Sale Of PPE: 15000000.00
BME.L income_statement (annual, 2022-03-31) — Selling General And Administration: 1142000000.00
BME.L balance_sheet (annual, 2022-03-31) — Share Issued: 1001226836.00
BME.L cash_flow (annual, 2022-03-31) — Short Term Debt Payments: 0.00
BME.L income_statement (annual, 2022-03-31) — Special Income Charges: 0.00
BME.L cash_flow (annual, 2022-03-31) — Stock Based Compensation: 2000000.00
BME.L balance_sheet (annual, 2022-03-31) — Stockholders Equity: 746000000.00
BME.L balance_sheet (annual, 2022-03-31) — Tangible Book Value: -294000000.00
BME.L income_statement (annual, 2022-03-31) — Tax Effect Of Unusual Items: 0.00
BME.L income_statement (annual, 2022-03-31) — Tax Provision: 103000000.00
BME.L income_statement (annual, 2022-03-31) — Tax Rate For Calcs: 0.20
BME.L balance_sheet (annual, 2022-03-31) — Taxes Receivable: 12000000.00
BME.L cash_flow (annual, 2022-03-31) — Taxes Refund Paid: -107000000.00
BME.L balance_sheet (annual, 2022-03-31) — Total Assets: 3638000000.00
BME.L balance_sheet (annual, 2022-03-31) — Total Capitalization: 1696000000.00
BME.L balance_sheet (annual, 2022-03-31) — Total Debt: 2266000000.00
BME.L balance_sheet (annual, 2022-03-31) — Total Equity Gross Minority Interest: 746000000.00
BME.L income_statement (annual, 2022-03-31) — Total Expenses: 4063000000.00
BME.L balance_sheet (annual, 2022-03-31) — Total Liabilities Net Minority Interest: 2892000000.00
BME.L balance_sheet (annual, 2022-03-31) — Total Non Current Assets: 2515000000.00
BME.L balance_sheet (annual, 2022-03-31) — Total Non Current Liabilities Net Minority Interest: 2137000000.00
BME.L income_statement (annual, 2022-03-31) — Total Operating Income As Reported: 610000000.00
BME.L income_statement (annual, 2022-03-31) — Total Other Finance Cost: 2000000.00
BME.L balance_sheet (annual, 2022-03-31) — Total Tax Payable: 66000000.00
BME.L income_statement (annual, 2022-03-31) — Total Unusual Items: 0.00
BME.L income_statement (annual, 2022-03-31) — Total Unusual Items Excluding Goodwill: 0.00
BME.L balance_sheet (annual, 2022-03-31) — Working Capital: 368000000.00
BME.L income_statement (annual, 2023-03-31) — +Operating Expense: 1265000000.00
BME.L income_statement (annual, 2023-03-31) — +Total Revenue: 4983000000.00
BME.L balance_sheet (annual, 2023-03-31) — Accounts Payable: 382000000.00
BME.L balance_sheet (annual, 2023-03-31) — Accounts Receivable: 9000000.00
BME.L balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -270000000.00
BME.L balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 2478000000.00
BME.L balance_sheet (annual, 2023-03-31) — Allowance For Doubtful Accounts Receivable: -2000000.00
BME.L cash_flow (annual, 2023-03-31) — Amortization Cash Flow: 4000000.00
BME.L income_statement (annual, 2023-03-31) — Basic Average Shares: 1001593000.00
BME.L income_statement (annual, 2023-03-31) — Basic EPS: 0.35
BME.L cash_flow (annual, 2023-03-31) — Beginning Cash Position: 173000000.00
BME.L balance_sheet (annual, 2023-03-31) — Buildings And Improvements: 1044000000.00
BME.L cash_flow (annual, 2023-03-31) — Capital Expenditure: -98000000.00
BME.L balance_sheet (annual, 2023-03-31) — Capital Lease Obligations: 1301000000.00
BME.L balance_sheet (annual, 2023-03-31) — Capital Stock: 100000000.00
BME.L balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 237000000.00
BME.L balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 237000000.00
BME.L cash_flow (annual, 2023-03-31) — Cash Dividends Paid: -366000000.00
BME.L balance_sheet (annual, 2023-03-31) — Cash Financial: 237000000.00
BME.L cash_flow (annual, 2023-03-31) — Change In Inventory: 103000000.00
BME.L cash_flow (annual, 2023-03-31) — Change In Payable: -30000000.00
BME.L cash_flow (annual, 2023-03-31) — Change In Receivables: 1000000.00
BME.L cash_flow (annual, 2023-03-31) — Change In Working Capital: 68000000.00
BME.L cash_flow (annual, 2023-03-31) — Changes In Cash: 61000000.00
BME.L balance_sheet (annual, 2023-03-31) — Common Stock: 100000000.00
BME.L cash_flow (annual, 2023-03-31) — Common Stock Dividend Paid: -366000000.00
BME.L balance_sheet (annual, 2023-03-31) — Common Stock Equity: 720000000.00
BME.L income_statement (annual, 2023-03-31) — Cost Of Revenue: 3182000000.00
BME.L balance_sheet (annual, 2023-03-31) — Current Assets: 1066000000.00
BME.L balance_sheet (annual, 2023-03-31) — Current Capital Lease Obligation: 177000000.00